GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zeo ScientifiX Inc (OTCPK:ZEOX) » Definitions » EPS (Basic)

ZEOX (Zeo ScientifiX) EPS (Basic) : $-0.78 (TTM As of Jan. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Zeo ScientifiX EPS (Basic)?

Zeo ScientifiX's basic earnings per share (Basic EPS) for the three months ended in Jan. 2025 was $-0.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2025 was $-0.78.

Zeo ScientifiX's EPS (Diluted) for the three months ended in Jan. 2025 was $-0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was $-0.78.

Zeo ScientifiX's EPS without NRI for the three months ended in Jan. 2025 was $-0.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2025 was -0.81.

During the past 3 years, the average EPS without NRI Growth Rate was 26.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zeo ScientifiX's highest 3-Year average EPS without NRI Growth Rate was 37.20% per year. The lowest was -256.90% per year. And the median was 0.00% per year.


Zeo ScientifiX EPS (Basic) Historical Data

The historical data trend for Zeo ScientifiX's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeo ScientifiX EPS (Basic) Chart

Zeo ScientifiX Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.00 -2.00 -1.56 -0.99 -0.74

Zeo ScientifiX Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.23 -0.16 -0.19 -0.20

Zeo ScientifiX EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zeo ScientifiX's Basic EPS for the fiscal year that ended in Oct. 2024 is calculated as

Basic EPS (A: Oct. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-4.705-0)/6.336
=-0.74

Zeo ScientifiX's Basic EPS for the quarter that ended in Jan. 2025 is calculated as

Basic EPS (Q: Jan. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.243-0)/6.345
=-0.20

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zeo ScientifiX  (OTCPK:ZEOX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zeo ScientifiX EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zeo ScientifiX's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zeo ScientifiX Business Description

Traded in Other Exchanges
N/A
Address
3321 College Avenue, Suite 246, Davie, FL, USA, 33314
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
Executives
Skycrest Holdings, Llc 10 percent owner 1930 HARRISON STREET, SUITE 204, HOLLYWOOD FL 33020
Harry L. Leider director, officer: CEO and Director C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Howard Lawrence Golub officer: Executive Vice President & CSO 23648 SEPTEMBER SUN SQ, ASHBURN VA 20148
Matthew Phillip Sinnreich officer: COO and Acting CEO 4045 SHERIDAN AVENUE, SUITE 239, MIAMI BEACH FL 33139
Steven Jerry Glauser director 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Leathem S Stearn director 2306 BAY DRIVE, POMPANO BEACH FL 33062
Charles Luther Bretz director 58 N. CHICAGO ST, 2ND FLOOR, JOLIET IL 60432
Bhupendra Kumar Modi director 6 MARINA BOULEVARD, #63-18, THE SALE @ MARINA BAY U0 018985
Gurvinder Pal Singh director E - 128, FIRST FLOOR, GREATER KAILASH - II, NEW DELHI K7 110048
John F Chiste director
Ryan C Likes officer: Chief Operating Officer 1116 MEADOWBROOK AVE., LOS ANGELES CA 90019
Greyt Ventures, Llc 10 percent owner GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180
Wendy Grey 10 percent owner GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180
Ian T Bothwell 10 percent owner, officer: Chief Financial Officer 77 530 ENFIELD LANE, BLDG D, PALM DESERT CA 92211
Albert Mitrani director, officer: Chief Executive Officer 4045 SHERIDAN AVE., SUITE 239, MIAMI BEACH FL 33140